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Abstract 
Background: This study is a collaboration between Macquarie University researchers and the Yaegl Aboriginal Com-
munity of northern NSW, Australia to investigate the antimicrobial potential of plants used in the topical treatment of 
wounds, sores and skin infections. Based on previously documented medicinal applications, aqueous and aqueous 
ethanolic extracts of Alocasia brisbanensis, Canavalia rosea, Corymbia intermedia, Hibbertia scandens, Ipomoea brasilien-
sis, Lophostemon suaveolens and Syncarpia glomulifera and the aqueous extracts of Smilax australis and Smilax glyci-
phylla were tested against common wound pathogens, including antibiotic resistant bacterial strains.
Methods: Plant material was prepared as aqueous extractions modelled on customary preparations and using 80% 
aqueous ethanol. Extracts were assayed against a selection of clinically relevant Gram positive (Streptococcus pyogenes 
and sensitive and resistant strains of Staphylococcus aureus) and Gram negative (Pseudomonas aeruginosa, Escherichia 
coli and Salmonella typhimurium) bacteria and a fungus (Candida albicans) using disc diffusion and MTT microdilution 
methods. Viability of treated microorganisms was determined by subculturing from microdilution assays.
Results: The extracts of Corymbia intermedia, Lophostemon suaveolens and Syncarpia glomulifera had promising levels 
of antimicrobial activity (MIC 31–1,000 µg/mL) against both antibiotic sensitive and resistant Staphylococcus aureus as 
well as the fungus Candida albicans (clinical isolate).
Conclusion: Aqueous and 80% aqueous ethanolic extracts of Lophostemon suaveolens, Corymbia intermedia and Syn-
carpia glomulifera exhibited promising levels of antimicrobial activity against a range of both antibiotic sensitive and 
resistant strains of microorganisms. This is the first report of antimicrobial activities for C. intermedia and L. suaveolens 
and the leaves of S. glomulifera. This study demonstrates the value of customary knowledge in the identification of 
new sources of antimicrobial treatments.
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Background
Australian Aboriginal people have over 40,000  years 
of knowledge of flora and fauna as sources of food, 
healing agents and other resources. Studies of custom-
ary (traditional and contemporary) medicinal plant 
preparations, especially in recent years, have revealed 
interesting medicinal properties and valuable biologically 
active compounds [1]. Australian Aboriginal medici-
nal flora have had limited biological screening studies 
aligned with their medicinal uses. Furthermore, the 
knowledge of their medicinal uses is quickly disappearing 
[2], particularly in some regions of the country, such as 
Open Access
*Correspondence:  subramanyam.vemulpad@mq.edu.au 
1 Indigenous Bioresources Research Group, Faculty of Science 
and Engineering, Macquarie University, North Ryde, Sydney 2109, 
Australia
Full list of author information is available at the end of the article
Page 2 of 7Packer et al. BMC Res Notes  (2015) 8:276 
the southern states of Australia. Assessment of the bioac-
tive potential of these plants with long historical use may 
support their wider application and also provide a source 
for safe, accessible alternative medicines and leads for the 
discovery of new drug-like molecules [3].
The ongoing crisis of antimicrobial resistance [4] calls 
for the investigation of novel sources of antimicrobi-
als. Working with Indigenous communities who have 
been using natural remedies over the centuries can pro-
vide novel sources of antimicrobial therapies and/or lead 
compounds for the development of new medicines [3].
Discussions with Elders of the Yaegl Aboriginal com-
munity of New South Wales, Australia on their custom-
ary (traditional and contemporary medicines) identified 
plants used in the topical treatment of conditions of a 
microbial aetiology [5]. These included Alocasia brisban-
ensis for burns and boils, cuts, sores and open wounds; 
Lophostemon suaveolens, Smilax australis, Smilax glyci-
phylla and Syncarpia glomulifera for antiseptic purposes; 
Canavalia rosea for boils and sores, Corymbia interme-
dia for the treatment of wounds; Hibbertia scandens for 
sores and rashes; and Ipomoea brasiliensis as a poultice 
for boils.
There has been little investigation into these plants 
identified by the Yaegl community for their antimicrobial 
potential. This study looks into the antimicrobial activity 
of these plants against eight pathogenic organisms com-
monly implicated in wounds, sores and skin infections.
Methods
Ethics protocol
This research was approved by the Human Ethics Com-
mittee at Macquarie University, (HE27 JUL2007-R05356 
and 5201200763). It was conducted under the frame-
work of best ethical practice, working in partnerships 
with Indigenous people [6, 7] and was governed by a 
cooperative research agreement with the Yaegl commu-
nity [8]. The choice of plants and the biological testing 
to be undertaken were determined in consultation with 
the Yaegl community through the Yaegl Local Aboriginal 
Land Council as the appropriate authorising body. The 
proposed methods and workflow were discussed before 
work commenced, and the results of the screening were 
presented back to the Yaegl community in the form of 
regular reports and presentations. The regular contact 
with the community during all phases of this research 
project ensured that the progress of the project remained 
in accordance with the requirements of the community 
and academics.
Plant collection and identification
Plants were collected in March 2011 after being located 
and identified with the assistance of the knowledge 
holders of the Yaegl community. Plant identification was 
confirmed by and voucher specimens deposited at the 
Herbarium of the Royal Botanic Gardens of NSW or the 
Macquarie University Herbarium [registered with the 
Index Herbariorum, New York Botanic Gardens (http://
sciweb.nybg.org/science2/IndexHerbariorum.asp)], with 
the prefix MQU.
For all plants the material used was leaves, except for 
I. brasiliensis where the stem and leaves were used. Plant 
material was weighed and washed twice with water to 
remove surface contaminants and extraneous mate-
rial. Approximately 50 g of fresh plant material for each 
extraction method was collected (except for S. australis 
and S. glyciphylla, where 10 g was collected for the aque-
ous extraction only, due to inadequate availability of the 
plant material in the area).
Chemicals
Unless otherwise indicated, all chemicals were sourced 
from Sigma Aldrich, St Louis, USA. All media listed 
below were sourced from Bacto Laboratories Pty Ltd, 
Australia and prepared as per the manufacturer’s 
instructions.
Extraction of plant material
Aqueous extraction of samples for antimicrobial screening
Plant material was, where possible, prepared in a way 
consistent with the preparation methods described by the 
Yaegl Elders [5] within 48 h of collection. In the case of 
pink bloodwood (C. intermedia) and apple gum (L. sua-
veolens or S. glomulifera), sap or latex while customarily 
used. Due to the risk of considerable damage to the tree, 
sap or latex was not collected and the Elders requested 
the leaves be collected and tested as an accessible and 
sustainable option. For C. rosea and H. scandens, the spe-
cifics of the preparation method could not be recalled by 
the knowledge holders.
Aqueous extractions were prepared as either a decoc-
tion or an infusion as described below.
Decoction (D): Plant material was pounded and boiled 
in 10× (w/v) tap water for 10  min, before being left to 
steep and cool (covered, for approximately 60 min). The 
decoction was filtered and the filtrate collected.
Hot infusion (I): Freshly boiled water was poured over 
roughly chopped or torn plant material (10× w/v). The 
infusion was covered and allowed to steep for 2  h. The 
infusion was filtered and the filtrate collected.
Cold infusion (CI): Plant material was roughly chopped 
or torn and submerged in 10× (w/v) water at room tem-
perature. The infusion was shaken gently for 24  h, the 
mixture was vacuum filtered and the solid was shaken 
with fresh water (10× w/v) for an additional 24 h and fil-
tered. The filtrates were pooled.
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All crude aqueous extracts were dried by rotary evapo-
ration (Büchi, Germany) at reduced pressure at approxi-
mately 50°C, followed by freeze drying (Labconco freeze 
dryer, USA). Extracts were stored at −20°C.
Aqueous ethanolic extraction of samples for antimicrobial 
screening
Fresh plant material was ground to a coarse powder using 
a coffee grinder (IKA® A11 Basic, Selangor, Malaysia) 
and shaken in 10× w/v of 80% v/v aqueous ethanol at 
room temperature [9] for approximately 48 h. The mix-
ture was filtered and the solid shaken with fresh 80% v/v 
aqueous ethanol (10× w/v) for an additional 48  h, and 
the filtrates pooled. The ethanolic portion was removed 
by rotary evaporation under reduced pressure at a low 
heat (<40°C), leaving the water portion, which was freeze 
dried and stored at −20°C.
Microbial strains
All extracts were initially screened against one Gram 
positive (Staphylococcus aureus ATCC 29213) and two 
Gram negative (Escherichia coli β-lactamase nega-
tive ATCC 25922 and Pseudomonas aeruginosa ATCC 
27853) bacterial strains, representing common patho-
gens associated with wounds, sores and skin infections 
[10, 11]. Selected extracts were also assayed against a 
broader range of microorganisms including: Streptococ-
cus pyogenes—Group A, clinical isolate; Salmonella typh-
imurium—Group B, clinical isolate; resistant S. aureus 
strains (ATCC BAA 1026 community acquired methicil-
lin resistant (CMRSA); wild multidrug resistant MRSA 
clinical isolate) and a yeast (Candida albicans—clinical 
isolate).
All microbial strains were kindly provided by Dr 
John Merlino (Department of Microbiology, Con-
cord Hospital, Sydney) and the work was approved 
by the Macquarie University Biosafety Committee 
(Approval Reference 08/06/LAB, JOP250512BHA, TAN-
180512BHA). Müller Hinton II (MH) broth was used as 
the liquid medium for all bacteria; MH agar was used for 
the growth of E. coli, S. aureus, S. typhimurium and P. 
aeruginosa strains; horse blood agar (Edwards Instru-
ments, Australia), was used for S. pyogenes. Potato dex-
trose agar (PDA, Oxoid, Basingstoke, UK) and Difco 
Sabouraud dextrose broth (SAB) were used for C. albi-
cans. Gentamycin was used as the antibiotic control for 
the sensitive strains of S. aureus, E. coli, S. typhimurium 
and P. aeruginosa, vancomycin for the resistant strains of 
S. aureus and penicillin G for S. pyogenes (all antibiot-
ics were supplied by Amresco, Ohio, USA). Fluconazole 
(MP Biomedicals, Ohio, USA) or miconazole (MP Bio-
medicals, LLC, France) was used as the antifungal con-
trol for the assays involving C. albicans.
Disc diffusion assay
Dried plant material was dissolved in DMSO at 50  mg/
mL. Antibiotic controls were prepared in broth at a con-
centration of 0.1  mg/mL. Sterile paper discs (∅ 6  mm, 
Whatman, Maidstone, UK) were impregnated with 
2 × 10 µL of plant extract (1 mg/disc) or antibiotic con-
trol (2 µg/disc) and air-dried. 20 µL DMSO impregnated 
discs were included as a negative control. Discs were 
placed on appropriate agar plates (horse blood agar for 
S. pyogenes, potato dextrose agar for C. albicans or MH 
agar for other microorganisms), inoculated with broth 
cultures at A600  =  0.08 (bacteria: 107–108  cfu/mL, C. 
albicans: 105 cfu/mL) and incubated at 37°C for 18–24 h 
(30°C for 48 h for C. albicans). The antimicrobial activ-
ity was measured as the zone of inhibition from the edge 
of the disc. Each sample and microbial combination was 
tested as at least four replicates.
MTT microdilution assay
The assay was performed as outlined by Steenkamp 
et al., with minor modifications [12]. Plant extracts were 
prepared at 10  mg/mL in MH broth/20% DMSO (or 
SAB/20% DMSO for C. albicans) and serially diluted 
to give 20  μL final plant sample concentrations of 
2–1,000  µg/mL (0.02–10  µg/mL of antibiotic control) 
in 96-well clear bottom microtitre plates. Test sam-
ples were inoculated with 175  µL of microbial culture 
(A600 = 0.08 diluted 1/100 in MH broth); a sterile broth 
control was included. The plates were incubated at 37°C 
for 18  h (30°C for C. albicans), 5  µL of a sterile metha-
nolic solution (5 mg/mL) of MTT was added to each well 
and incubated at 37°C for 60 min. The MIC was the low-
est concentration of test material in which no growth (as 
measured by no blue colour) was observed [13].
Microbial viability determination
Plant extracts with antimicrobial activity (Table  1), 
as determined by the MTT microdilution assay, were 
assessed for their microbicidal/static nature by subcul-
turing onto fresh agar plates after the assay [14]. Sub-
cultures not producing colonies were deemed to have 
been affected by the plant extract by a microbicidal 
mechanism. The minimum microbicidal concentration 
was defined as the concentration of the plant extract in 
the last well showing no further microbial growth on 
subculture.
Results
Aqueous or 80% aqueous ethanolic extracts from nine 
plants used by the Yaegl community were initially tested 
against the Gram positive and Gram negative antibi-
otic sensitive bacteria, S. aureus (ATCC 29213), E. coli 
(β-lactamase negative, ATCC 25922) and P. aeruginosa 
Page 4 of 7Packer et al. BMC Res Notes  (2015) 8:276 
(ATCC 27853) using the disc diffusion and MTT assays. 
The plant extracts showed activity only against S. aureus 
(in both disc diffusion and MTT assays) and P. aerugi-
nosa (in disc diffusion assay only). L. suaveolens, C. inter-
media and S. glomulifera extracts had the highest levels 
of antimicrobial activity (Table 1).
Antimicrobial activity for mixtures or crude plant 
extracts of between 0.1 and 1  mg/mL have been sug-
gested as being appropriate for further investigation 
[15]. L. suaveolens, C. intermedia and S. glomulifera 
crude plant extracts were therefore further investigated 
as they had MIC values ≤500  µg/mL (Table  1). These 
extracts were tested against a broader spectrum of 
microorganisms viz. Candida albicans, Streptococcus 
pyogenes, Salmonella typhimurium and resistant strains 
of S. aureus—multidrug resistant (MDRSA) and commu-
nity acquired methicillin resistant (CMRSA). Table 2 (and 
Additional file 1) presents the activities of these extracts. 
Results for S. typhimurium are not included as no activ-
ity was observed with any of the three plants. The 80% 
aqueous ethanolic extract of S. glomulifera was the most 
active of the extracts, based on low MIC values (31 µg/
mL) against the tested bacteria as well as C. albicans. The 
80% aqueous ethanolic extracts of both L. suaveolens and 
S. glomulifera were microbicidal in their activity against 
the susceptible microorganisms.
Table 1 Initial screening for antimicrobial activity of extracts of plants used customarily to treat skin conditions
na no activity detected.
a Leaves of plants used in all cases except where indicated.
b Extraction method used: H2O—based on traditional preparation (D, decoction; I, infusion; CI, cold infusion), EtOH—80% aqueous ethanol.
c Values given are inhibition in mm from the edge of the disc; average (range) of 4 replicates.
d MIC noted as µg/mL, based on the last dilution of extract not to exhibit yellow–blue colour change in MTT assay; values given are median (range) of four replicates.
A Leaves and stems.
Planta (voucher number) Extractb Pseudomonas aeruginosa  
(ATCC 27853)
Staphylococcus aureus  
(ATCC 29213)
Disc diffusionc MTTd Disc diffusionc MTTd
Average (range) MIC median 
(range)
Average (range) MIC median 
(range)
Apple gum
 Lophostemon suaveolens (Sol. ex Gaertn.) Peter G. 
Wilson & J.T. Waterh (MQ 73008908)
H2O (I) na na 2 (1–3) 188 (125–250)
EtOH na na 3 (2.5–3.5) 93 (63–125)
 Syncarpia glomulifera  
subsp. glomulifera (Sm.) Nied. (MQ 73009066)
H2O (I) 5.5 (0–10) na 6.5 (5–10) 300 (250–500)
EtOH na na 3 (3–6) 63 (31–63)
Beach morning glory
 Ipomoea brasiliensis (L.) Sweet (MQ 73007958)A H2O (D) na na na na
EtOH na na na na
Bloodwood
 Corymbia intermedia (R.T. Baker) K.D. Hill & L.A.S. John-
son (NSW 792670)
H2O (I) 1 (1) na 2 (1–3.5) 250 (250–500)
EtOH na na 2.5 (2–4) 299 (174–500)
Coastal jackbean
 Canavalia rosea (Sw.) DC. (MQ 73008909) H2O (D) na na na na
EtOH na na na na
Cunjevoi
 Alocasia brisbanensis Domin (MQ 73008737) H2O (D) na na na na
EtOH na na na na
Sarsaparilla
 Smilax australis R.Br. (wide leaf ) (NSW 792674) H2O (I) na na na na
 Smilax glyciphylla Sm. (narrow leaf ) (NSW 792380) H2O (I) na na na na
Yellowvine
 Hibbertia scandens (Willd.) Gilg (MQ 73008905) H2O (D) na na na na
EtOH na na na na
 Antibiotic control (Gentamycin) 8 (8) 1.25 8 (8) 0.5
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Discussion
Ethnobotanical studies conducted by us with Yaegl Abo-
riginal Elders of northern New South Wales, Australia, 
described the use of Alocasia brisbanensis, Canavalia 
rosea, Corymbia intermedia, Hibbertia scandens, Ipomoea 
brasiliensis, Lophostemon suaveolens, Smilax australis, 
Smilax glyciphylla and Syncarpia glomulifera for the treat-
ment of wounds, sores and skin infections [5]. None of 
these plants have been investigated for their antimicrobial 
activity, with the exception of C. rosea [16]. The success 
of finding antimicrobial activity and bioactive compounds 
of medicinal value from traditional/customary medicines 
[3], prompted the investigation of these plants.
The plants were extracted with water to mimic the 
common customary practice of the community and/or 
with 80% aqueous ethanol, as a standard natural products 
research method [9]. The plant parts extracted were the 
same as those used by the Yaegl community, except for 
bloodwood (C. intermedia) and apple gum (L. suaveolens 
or S. glomulifera), where customarily the sap or latex was 
used in the treatment of wounds. However, as sap or latex 
were not readily accessible, we tested the leaves at the 
request of the Yaegl Elders.
The microorganisms selected for the assays are com-
monly implicated in wounds, sores and skin infections 
[11]. The two assay methods were chosen as they comple-
ment each other in that the disc diffusion assay is simple 
but not always appropriate for non-polar and large mol-
ecules [17] and the more sensitive, versatile and quantita-
tive MTT microdilution assay can have interference with 
the colour and redox activity of plant extracts.
The extracts of C. intermedia, L. suaveolens and S. glomu-
lifera had reasonable levels of antimicrobial activity (MIC 
0.1–1 mg/mL; [15]) against antibiotic sensitive and resist-
ant Staphylococcus aureus as well as the fungus Candida 
albicans (clinical isolate). Although antibacterial activity of 
the ethanolic extract of C. rosea leaves has been previously 
reported against S. aureus, albeit at a low level [16], no anti-
bacterial activity was seen in this study, possibly due to the 
different bacterial strains and assay conditions used.
The 80% aqueous ethanolic extracts of C. intermedia, 
L. suaveolens and S. glomulifera were substantially more 
active than the aqueous extracts. This indicates that the 
antimicrobial components in these plants were more 
easily extractable in 80% aqueous ethanol. S. glomulifera 
was the most active of the extracts (Table  2). The 80% 
aqueous ethanolic extracts of both L. suaveolens and S. 
glomulifera were microbicidal in their activity against the 
susceptible microorganisms.
Sap from bloodwood (C. intermedia) has been used by 
the Yaegl community in the treatment of wounds [5]. No 
chemical or biological studies have been reported for C. 
intermedia. Milky sap and ash from the bark of the apple 
gum (Lophostemon suaveolens or Syncarpia glomulifera) 
have been used as antiseptics by the Yaegl community 
[5]. These two plants are sometimes interchangeably used 
due to their similar morphology.
No antimicrobial activity studies have been reported 
for L. suaveolens or the leaves of S. glomulifera. How-
ever, both plants have been found to contain the follow-
ing compounds that have been independently reported 
for antimicrobial activity [18–22]. Leaves of L. suaveolens 
have been found to contain α-pinene, β-caryophyllene, 
aromadendrene, globulol and spathulenol [23], which 
have been independently reported for antimicrobial activ-
ity. The leaves of S. glomulifera also contain α-pinene, 
aromadendrene and globulol [24]. Eucalyptin, which has 
been reported to be antibacterial, has been found in the 
leaf wax of S. glomulifera [25]. Additionally, S. glomulifera 
bark has been reported to be antibacterial and to con-
tain the antibacterial compounds betulinic acid, oleanolic 
acid-3-acetate and ursolic acid-3-acetate [26].
This is the first report of antimicrobial activities for C. 
intermedia and L. suaveolens and the leaves of S. glomu-
lifera. These results warrant further investigation of the 
active ingredients of these medicinal plants.
Conclusion
80% aqueous ethanolic extracts of Lophostemon sua-
veolens and Syncarpia glomulifera showed microbicidal 
activity at concentrations of <200 µg/mL against C. albi-
cans and both sensitive and resistant strains of S. aureus. 
Aqueous extracts of L. suaveolens and S. glomulifera 
and aqueous and ethanolic extracts of Corymbia inter-
media exhibited microbicidal activity against a range of 
both antibiotic sensitive and resistant strains of micro-
organisms at levels below 1,000  µg/mL. This is the first 
report of antimicrobial activities for C. intermedia and 
L. suaveolens and the leaves of S. glomulifera. This study 
demonstrates the value of customary knowledge in the 
identification of new sources of antimicrobial treatments.
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